Skip to content
thispeptide

Defy Medical

Defy Medical offers consultations and testing for hormone, weight and peptide treatment. Its public team is named, but medication pricing is largely in the patient portal or separate handouts rather than a simple monthly menu.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

The laboratory and consultation pathway is more detailed than a questionnaire-only sale. The wide peptide menu still requires caution: named clinicians and pharmacy partners do not establish the benefits or regulatory status of every proposed compound.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Defy Medical, LLC is a telemedicine clinic with an office in Florida. Its public services include semaglutide and tirzepatide weight care, sermorelin and other peptide discussions. It also mentions liraglutide as an alternative. Public semaglutide and PT-141 handouts give per-vial figures, with pharmacies named for PT-141. A separate patient-portal FAQ says non-patients cannot view medication ordering prices until they establish care.

What Defy Medical prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      • LiraglutideFDA-approved

        Listed by the seller; no price we hold.

        The clinician evaluates possible contributors to weight problems, including metabolic and thyroid conditions. Public pages discuss semaglutide and tirzepatide alongside other interventions. A prescription and dose are individualized. The semaglutide handout’s monthly cost illustration excludes visits, labs, shipping and tax and is expressly not a price guarantee.

        Sexual health

        The PT-141 handout describes an injection, a particular vial strength and off-label uses beyond branded Vyleesi’s indication. The safety and suitability of a compounded preparation must be evaluated separately from the approval of the brand.

        Recovery

        • SermorelinCompounding conditions apply

          Listed by the seller; no price we hold.

          Sleep

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Who prescribes

            A licensed clinician

            The care team is led by medical director and practicing physician Justin Saya, MD. The provider directory lists a clinical network of additional physicians and advanced-practice clinicians. Defy manages medical care and orders, while pharmacy partners fill prescriptions. Its handouts identify Empower, Hallandale and APS for particular products. That historical product list does not guarantee which pharmacy will dispense a new prescription. FDA’s September 2026 letter to Empower Pharmacy raises manufacturing and compounding concerns. It addresses the pharmacy, not Defy, and does not identify a particular Defy patient’s order.

            New patients provide medical history, undergo required testing and have a consultation before any prescription. The terms require compliance with requested bloodwork, physical examinations and follow-up before refills. Out-of-state patients must provide periodic physical examinations when required. The weight handout describes check-ins three months after starting care, followed by six-month reviews once established. The clinic also states there are no subscriptions or contracts for that service.

            Are labs required?

            Required and separate

            Blood testing and provider review are part of establishing and maintaining care. A 2023 semaglutide handout lists historical panel and consultation figures. Current terms permit price changes, so request the required testing and its present cost.

            Ready to start with Defy Medical?

            Prices and plans are set on the seller's own site.

            What it claims, and what it cites

            The tirzepatide page cites Jastreboff’s trial while describing a 15–25% reduction in six months. The cited SURMOUNT-1 trial measured its main weight outcomes at 72 weeks, so the page’s time frame should not be relied on. That trial also does not validate every compounded formulation or Defy’s entire service. The broader peptide page includes compounds with limited human evidence and does not establish a controlled trial of the clinic’s complete protocol.

            Other products and treatment claims

            BPC-157, TB-500, epithalon, MOTS-C and other research-stage peptide offers
            These are not included as eligible clinical price comparisons; a clinic listing does not establish approval or sufficient human evidence.

            How it bills

            A 2023 semaglutide handout lists an $80 vial; a 2020 PT-141 sheet lists a 2 mL vial at 10 mg/mL for $205. These are dated document figures, not verified current offers. The current service pages reviewed do not link either price sheet. Medication ordering prices are restricted to established patients. Request the current prescription quantity and itemized quote before comparing costs. The current terms make most sales final. Consultations are not refundable merely because a prescription is not recommended. Late-canceled appointments can incur the full visit fee, while unused lab orders have a separate credit process and processing fee. Insurance reimbursement is not guaranteed.

            For and against

            • For: Medical director and providers identified
            • For: Testing and follow-up requirements published
            • For: Per-vial handouts name pharmacies
            • For: No weight-program subscription required
            • Against: Medication ordering prices largely portal-based
            • Against: Public claims need careful checking
            • Against: Pharmacy regulatory history matters
            • Against: No universal monthly peptide total

            The evidence behind what it sells

            Right for

            Someone seeking a thorough clinical assessment who will question the evidence, exact prescription and pharmacy before proceeding.

            Look elsewhere if

            A buyer looking for a simple low monthly peptide bundle or treating every clinic-listed compound as an established therapy.

            Other sellers for weight

            Defy Medical

            Frequently asked questions

            Are the public vial figures monthly prices?
            No. Duration depends on the actual prescribed dose, so a vial cannot be converted into a month without that information.
            Who leads the clinical team?
            The public team page names Justin Saya, MD, as medical director and lead practicing physician.
            Does a pharmacy letter mean Defy received that warning?
            No. The cited letter is addressed to Empower Pharmacy. It is relevant pharmacy history, not a letter addressed to Defy Medical.

            Sources

            See what Defy Medical prescribes today

            Defy Medical sets its own prices, plans and the states it serves. Check them before you start.

            Written by Molly Ward from Defy Medical’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.